Literature DB >> 33456570

Activation of EP4 receptor limits transition of acute to chronic heart failure in lipoxygenase deficient mice.

Vasundhara Kain1, Kevin A Ingle2, Namakkal S Rajasekaran3, Ganesh V Halade1.   

Abstract

Aim: Immune responsive 12/15 lipoxygenase (12/15LOX)-orchestrate biosynthesis of essential inflammation-resolution mediators during acute inflammatory response in post-myocardial infarction (MI). Lack of 12/15LOX dampens proinflammatory mediator 12-(S)-hydroxyeicosatetraenoic acid (12-(S)-HETE), improves post-MI survival, through the biosynthesis of endogenous mediators epoxyeicosatrienoic acids (EETs; cypoxins) to resolve post-MI inflammation. However, the mechanism that amplifies cypoxins-directed cardiac repair in acute heart failure (AHF) and chronic HF (CHF) remains of interest in MI-directed renal inflammation. Therefore, we determined the role of EETs in macrophage-specific receptor activation in facilitating cardiac repair in 12/15LOX deficient mice experiencing HF. Methods and
Results: Risk-free young adult (8 -12 week-old) male C57BL/6J wild-type mice (WT; n = 43) and 12/15LOX-/- mice (n = 31) were subjected to permanent coronary artery ligation and monitored at day (d)1, d5 (as acute HF), and d28 to d56 (8 weeks; chronic HF) post-surgery maintaining no-MI mice that served as d0 naïve controls. Left ventricle (LV) infarcted area of 12/15LOX-/- mice displayed an increase in expression of prostanoid receptor EP4 along with monocyte chemoattractant protein-1 CCL2 in AHF and CHF. The transcriptome analysis of isolated leukocytes (macrophages/neutrophils) from infarcted LV revealed a higher expression of EP4 on reparative macrophages expressing MRC-1 in 12/15LOX-/- mice. Deletion of 12/15LOX differentially modulated the miRNA levels, downregulating miR-23a-3p (~20 fold; p < 0.05) and upregulating miR-125a-5p (~160 fold; p < 0.05) in AHF which promoted polarization of the macrophages towards reparative phenotype. Furthermore, 12/15LOX deletion markedly attenuated renal inflammation with reduced levels of NGAL and KIM-1 and apoptotic markers in the kidney during CHF.
Conclusion: In risk-free mice during physiological cardiac repair, absence of 12/15LOX promoted reparative macrophages with marked activation of EP4 signaling thereby improving post-MI survival and limiting renal inflammation in acute and advanced HF. The future studies are warranted to advance the role of EETs in macrophage receptor biology. © The author(s).

Entities:  

Keywords:  Inflammation; cardiac remodeling; heart failure; leukocytes; macrophages; resolution

Year:  2021        PMID: 33456570      PMCID: PMC7806484          DOI: 10.7150/thno.51183

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


  45 in total

Review 1.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

2.  Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury.

Authors:  Keiichi Hishikari; Jun-ichi Suzuki; Masahito Ogawa; Kazuya Isobe; Teisuke Takahashi; Michihito Onishi; Kiyoshi Takayama; Mitsuaki Isobe
Journal:  Cardiovasc Res       Date:  2008-09-18       Impact factor: 10.787

3.  Immune responsive resolvin D1 programs peritoneal macrophages and cardiac fibroblast phenotypes in diversified metabolic microenvironment.

Authors:  Vasundhara Kain; Ganesh V Halade
Journal:  J Cell Physiol       Date:  2018-09-07       Impact factor: 6.384

4.  Splenic leukocytes define the resolution of inflammation in heart failure.

Authors:  Ganesh V Halade; Paul C Norris; Vasundhara Kain; Charles N Serhan; Kevin A Ingle
Journal:  Sci Signal       Date:  2018-03-06       Impact factor: 8.192

Review 5.  ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  Sharon Ann Hunt
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

6.  Lipoxygenase drives lipidomic and metabolic reprogramming in ischemic heart failure.

Authors:  Ganesh V Halade; Vasundhara Kain; Bochra Tourki; Jeevan Kumar Jadapalli
Journal:  Metabolism       Date:  2019-04-15       Impact factor: 8.694

7.  Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement.

Authors:  J A Erlebacher; J L Weiss; M L Weisfeldt; B H Bulkley
Journal:  J Am Coll Cardiol       Date:  1984-08       Impact factor: 24.094

8.  Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.

Authors:  Vasundhara Kain; Kevin A Ingle; Janusz Kabarowski; Stephen Barnes; Nita A Limdi; Sumanth D Prabhu; Ganesh V Halade
Journal:  J Mol Cell Cardiol       Date:  2018-03-08       Impact factor: 5.000

9.  A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression.

Authors:  Sisi Ma; Min Liu; Zhenbiao Xu; Yanshuang Li; Hui Guo; Yehua Ge; Yanxin Liu; Dexian Zheng; Juan Shi
Journal:  Oncotarget       Date:  2016-03-22

10.  Molecular and Cellular Differences in Cardiac Repair of Male and Female Mice.

Authors:  Amanda B Pullen; Vasundhara Kain; Charles N Serhan; Ganesh V Halade
Journal:  J Am Heart Assoc       Date:  2020-04-16       Impact factor: 5.501

View more
  2 in total

Review 1.  Inflammation and resolution signaling in cardiac repair and heart failure.

Authors:  Ganesh V Halade; Dae Hyun Lee
Journal:  EBioMedicine       Date:  2022-04-08       Impact factor: 11.205

2.  MicroRNAs Promote the Progression of Sepsis-Induced Cardiomyopathy and Neurovascular Dysfunction Through Upregulation of NF-kappaB Signaling Pathway-Associated HDAC7/ACTN4.

Authors:  Qiancheng Luo; Hanning Ma; Enwei Guo; Lin Yu; Ling Jia; Bingyu Zhang; Gang Feng; Rui Liu
Journal:  Front Neurol       Date:  2022-06-09       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.